Sunstein Insights Shape Created with Sketch.

Back to All Publications

The Name Game: The USPTO and FDA approval process for the selection and protection of new drug names.

Lisa M. Tittemore

Lisa M. Tittemore | Partner, Litigation Chair View more articles

Lisa is a member of our Litigation Practice Group and Trademark Practice Group

File no longer available.

We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.

Subscribe to our Newsletters

Subscribe to: